Logo-jnp
Original Article

1. Association of serum fibroblast growth factor 23 with calcium metabolism in patients with end-stage renal disease undergoing hemodialysis
Niloufar Alimohammadi, Parisa Javadian*, Afsaneh Malekpour, Shahram Tahmasebian
J Nephropathol. 2017;6(4): 352-355. doi: 10.15171/jnp.2017.57
Scopus ID: 85036584059    
Article
PDF
XML
Cited By:
0
0
Original Article

2. Impact of fibroblast growth factor-23 on blood pressure and pulse pressure in hemodialysis patients; a multicenter study
Farzanehsadat , Minoo, Mahdieh Jamshidi, Elham Ramezanzadeh*, Mohammadtaghi Najafi, Azam Alamdari
J Nephropathol. 2019;8(1): e09. doi: 10.15171/jnp.2019.09
Scopus ID: 85065969565    
Article
PDF
XML
Cited By:
0
0
Original Article

3. Does fibroblast growth factor 23 correlates with volume status in hemodialysis patients?
Farzanehsadat Minoo ORCID, Azam Alamdari* ORCID, Hamed Karimi
J Nephropathol. 2019;8(4): e35. doi: 10.15171/jnp.2019.35
Scopus ID: 85075007876    
Article
PDF
XML
Cited By:
0
1
Original Article

4. Correlation of serum fibroblast growth factor-23 levels and calcium phosphate products levels in chronic kidney disease; sub analysis of chronic kidney disease-mineral and bone disorder study
Adeh Mahardika* ORCID, Hasyim Kasim ORCID, Syakib Bakri ORCID, Haerani Rasyid ORCID, Husaini Umar ORCID, Nu’man AS Daud ORCID, Wasis Udaya ORCID, Arifin Seweng ORCID
J Nephropathol. 2024;13(4): e20416. doi: 10.34172/jnp.2024.20416
Article
PDF
XML
Cited By:
0
Review

5. Osseointegration challenges of dental implants in dialysis-dependent chronic kidney disease patients
Muhanad Muhssin Ali* ORCID
J Nephropathol. 2026;. doi: 10.34172/jnp.28724
Article
PDF
XML
Cited By: